CpG hypermethylation contributes to decreased expression of PTEN during acquired resistance to gefitinib in human lung cancer cell lines
Keywords: Gefitinib-resistance; PTEN; DNA methylation; Lung cancer; EGR-1; EGFR-tyrosine kinase inhibitor